CytomX Therapeutics Revenue (TTM) Analysis

CytomX Therapeutics Inc (CTMX)

1.73 -0.03 (-1.70%) USD | NASDAQ | Apr 18, 16:00

1.72 -0.01 (-0.58%) After-Hours: 20:00

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	101.21M
September 30, 2023	94.73M
June 30, 2023	79.49M
March 31, 2023	67.62M
December 31, 2022	53.16M
September 30, 2022	20.51M
June 30, 2022	26.95M
March 31, 2022	30.38M
December 31, 2021	37.31M
September 30, 2021	34.28M
June 30, 2021	34.48M
March 31, 2021	34.80M
December 31, 2020	68.43M
September 30, 2020	61.68M
June 30, 2020	54.60M
March 31, 2020	47.01M
December 31, 2019	26.90M
September 30, 2019	60.68M

Date	Value
June 30, 2019	62.48M
March 31, 2019	74.80M
December 31, 2018	59.50M
September 30, 2018	75.10M
June 30, 2018	86.74M
March 31, 2018	74.15M
December 31, 2017	71.62M
September 30, 2017	50.82M
June 30, 2017	30.13M
March 31, 2017	24.47M
December 31, 2016	15.04M
September 30, 2016	10.76M
June 30, 2016	9.244M
March 31, 2016	8.193M
December 31, 2015	7.712M
September 30, 2015	7.585M
June 30, 2015	7.561M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

20.51M

Minimum

Sep 2022

101.21M

Maximum

Dec 2023

52.46M

Average

53.16M

Median

Dec 2022

Revenue (TTM) Benchmarks